XOMA Corp (XOMA)
25.82
+0.48
(+1.89%)
USD |
NASDAQ |
May 01, 16:00
26.00
+0.18
(+0.70%)
After-Hours: 20:00
XOMA 1 Year Total Returns (Daily): 41.73% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | 41.73% |
April 30, 2024 | 40.61% |
April 29, 2024 | 47.05% |
April 26, 2024 | 35.05% |
April 25, 2024 | 42.35% |
April 24, 2024 | 44.08% |
April 23, 2024 | 43.29% |
April 22, 2024 | 41.81% |
April 19, 2024 | 34.37% |
April 18, 2024 | 28.88% |
April 17, 2024 | 27.36% |
April 16, 2024 | 26.48% |
April 15, 2024 | 26.27% |
April 12, 2024 | 27.07% |
April 11, 2024 | 23.89% |
April 10, 2024 | 22.47% |
April 09, 2024 | 35.62% |
April 08, 2024 | 33.66% |
April 05, 2024 | 30.14% |
April 04, 2024 | 33.10% |
April 03, 2024 | 25.22% |
April 02, 2024 | 27.38% |
April 01, 2024 | 19.61% |
March 28, 2024 | 13.34% |
March 27, 2024 | 10.98% |
Date | Value |
---|---|
March 26, 2024 | 6.34% |
March 25, 2024 | 10.24% |
March 22, 2024 | 27.57% |
March 21, 2024 | 25.92% |
March 20, 2024 | 25.36% |
March 19, 2024 | 26.44% |
March 18, 2024 | 26.34% |
March 15, 2024 | 29.46% |
March 14, 2024 | 24.92% |
March 13, 2024 | 21.78% |
March 12, 2024 | 18.48% |
March 11, 2024 | 21.39% |
March 08, 2024 | 17.55% |
March 07, 2024 | 18.27% |
March 06, 2024 | 17.15% |
March 05, 2024 | 14.27% |
March 04, 2024 | 16.03% |
March 01, 2024 | 14.96% |
February 29, 2024 | 14.24% |
February 28, 2024 | 17.25% |
February 27, 2024 | 13.30% |
February 26, 2024 | 14.63% |
February 23, 2024 | 11.05% |
February 22, 2024 | 10.09% |
February 21, 2024 | 16.78% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-55.40%
Minimum
Feb 08 2022
151.6%
Maximum
Dec 24 2019
10.16%
Average
2.58%
Median
Mar 18 2020
1 Year Total Returns (Daily) Benchmarks
Kinnate Biopharma Inc (DELISTED) | -- |
Societal CDMO Inc (DELISTED) | 2.80% |
Corcept Therapeutics Inc | 4.87% |
Sarepta Therapeutics Inc | 4.52% |
AnaptysBio Inc | 22.77% |